LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Adenosine Injection, USP in 60 mg per 20 mL and 90 mg per 30 mL presentations.
Astellas currently markets Adenoscan (R) (adenosine injection), the leading pharmacologic stress agent for MPI studies in the United States. Adenoscan is indicated as an adjunct to thallium-201 ...
SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Ltd. said Monday the Food and Drug Administration has granted tentative approval for its Adenosine injection, 3 mg/mL in 20 mL and 30 mL ...
A double injection of intracoronary adenosine improves myocardial reperfusion as well as early clinical outcomes in patients receiving primary percutaneous coronary intervention (PCI) for acute ...
April 15, 2008 (Palo Alto, CA and Deerfield, IL) - The US Food and Drug Administration has market-approved regadenoson (Lexiscan), a selective A 2A adenosine-receptor agonist, for resting ...
JERUSALEM — Teva Pharmaceutical Industries has become the first to launch a generic drug for treating certain heart patients, the company said. Teva announced the launch of adenosine injection, a ...
Nicorandil, a vasodilator, appears to effectively induce hyperemia during fractional flow reserve (FFR) measurement with few adverse events. The drug may prove to be a more convenient, safer ...
Astellas currently markets Adenoscan (R) (adenosine injection), the leading pharmacologic stress agent for MPI studies in the United States. Adenoscan is indicated as an adjunct to thallium-201 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results